<--- Back to Details
First PageDocument Content
Oncology / Trastuzumab / Hepatology / Breast cancer / Metastatic breast cancer / Management of cancer / Metastatic liver disease / Lung cancer / Metastasis / Medicine / Cancer treatments / Ribbon symbolism
Date: 2012-10-16 04:51:36
Oncology
Trastuzumab
Hepatology
Breast cancer
Metastatic breast cancer
Management of cancer
Metastatic liver disease
Lung cancer
Metastasis
Medicine
Cancer treatments
Ribbon symbolism

Overall survival in metastatic breast cancer patients: a single-centre analysis[removed])

Add to Reading List

Source URL: edoc.ub.uni-muenchen.de

Download Document from Source Website

File Size: 969,85 KB

Share Document on Facebook

Similar Documents

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

DocID: 1uQqF - View Document

Jose Falcon Father, Co-Survivor and Veteran Tour de Pink Rider My name is Jose Falcon and I am the proud father and caregiver to my only daughter, Kayla Falcon. She was diagnosed with Stage 4 Metastatic breast cancer at

Jose Falcon Father, Co-Survivor and Veteran Tour de Pink Rider My name is Jose Falcon and I am the proud father and caregiver to my only daughter, Kayla Falcon. She was diagnosed with Stage 4 Metastatic breast cancer at

DocID: 1trwM - View Document

· METASTATIC BREAST CANCER ·  Assessing Treatment Response in Metastatic Breast Cancer Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD  Abstract

· METASTATIC BREAST CANCER · Assessing Treatment Response in Metastatic Breast Cancer Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD Abstract

DocID: 1rmV3 - View Document

Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer

Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer

DocID: 1riiF - View Document

Media release, October 23, 2014  Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scienti

Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scienti

DocID: 1rf3r - View Document